Rockefeller Capital Management L.P.

Position in BEAM — Beam Therapeutics Inc.

CIK 1739439 NEW YORK, NY

Position in BEAM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$139,544

+$79,208 QoQ

Shares Held

4,066

+60.6% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#194

of 274 holders

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 36% Shared 0% None 64%

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $307,135,875 across 241 Biotechnology names. BEAM ranks #71 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	149,476	$74,249,211
2	JAZZ	Jazz Pharmaceuticals plc	167,409	$40,340,545
3	ACAD	Acadia Pharmaceuticals Inc	1,015,420	$25,690,124
4	BMRN	Biomarin Pharmaceutical Inc	433,376	$24,797,774
5	PTCT	Ptc Therapeutics, Inc.	302,393	$24,666,195
6	MDGL	Madrigal Pharmaceuticals, Inc.	29,015	$15,579,603
7	REGN	Regeneron Pharmaceuticals, Inc.	21,563	$13,445,391
8	CORT	Corcept Therapeutics Inc	123,388	$10,728,585

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$139,544	4,066	+60.6%	Shares	Defined	2026-08-13
2026-03-31	$60,336	2,532	+94.9%	Shares	Defined	2026-05-14
2025-12-31	$36,007	1,299	+8.4%	Shares	Defined	2026-03-17
2025-09-30	$29,075	1,198	-2.4%	Shares	Defined	2025-11-14
2022-12-31	$48,027	1,228	0.0%	Shares	Defined	2023-03-06
2022-09-30	$58,501	1,228	-28.3%	Shares	Defined	2022-11-02
2022-06-30	$66,310	1,713	+35.4%	Shares	Defined	2022-08-12
2022-03-31	$72,484	1,265	+3.0%	Shares	Defined	2022-05-13
2021-12-31	$97,859	1,228	0.0%	Shares	Defined	2022-02-14
2021-09-30	$106,848	1,228	0.0%	Shares	Defined	2021-11-12
2021-06-30	$158,055	1,228	0.0%	Shares	Defined	2021-08-10
2021-03-31	$98,289	1,228	0.0%	Shares	Defined	2021-05-11
2020-12-31	$100,253	1,228	+53.5%	Shares	Defined	2021-02-12
2020-09-30	$19,696	800	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.